Highmark Health’s VITAL Program to Evaluate Avinger’s Novel Treatment for Peripheral Artery Disease
June 27, 2016 16:01 ET
|
Avinger Inc
PITTSBURGH and REDWOOD CITY, Calif., June 27, 2016 (GLOBE NEWSWIRE) -- Highmark Health, Allegheny Health Network (AHN) and Avinger, Inc. (NASDAQ:AVGR) announced a collaboration today to evaluate...
Avinger, Inc. Announces Drawdown of $10 Million Under Term Loan Facility with CRG
June 15, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., June 15, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that it has...
Avinger, Inc. Announces First Quarter 2016 Results
May 04, 2016 16:01 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the...
Avinger, Inc. to Announce First Quarter 2016 Results on Wednesday, May 4, 2016
April 27, 2016 16:01 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
Avinger, Inc. Announces Fourth Quarter and Full Year 2015 Results
March 01, 2016 16:05 ET
|
Avinger, Inc.
Pantheris™ Commercial Launch Underway REDWOOD CITY, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral...
Avinger Announces FDA Clearance and U.S. Launch of Breakthrough Treatment for Patients With Peripheral Artery Disease
March 01, 2016 16:03 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the...
Avinger, Inc. to Present Cowen and Company 36th Annual Health Care Conference
February 23, 2016 16:05 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial...
Avinger, Inc. to Announce Fourth Quarter and Year-End 2015 Results on Tuesday, March 1, 2016
February 18, 2016 08:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial...
Avinger, Inc. Names Joseph Rafferty as Vice President of Sales
January 04, 2016 16:03 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial...
Avinger Announces Filing of 510(k) Application for Enhanced Version of Pantheris(TM)
December 01, 2015 16:25 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial...